Kristin M Bircsak

Mimetas Us, Inc.

$618,390

Attributed

$1,236,779

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY2020–22

$1M$750K$500K$250K$0

'20

'21

'22

Funding mix

By agency

NIH$1,236,779 · 2

By mechanism

R44$1,000,000 · 1

R43$236,779 · 1

Top collaborators

Laura Perin2 shared

Most similar at Mimetas Us, Inc.

Same institution · by research overlap

Morgan Chandler$496,573

Others in their field

Other Emerging Leaders on “Glomerular Filtration”

Vera Hoffman · Reveal Pharma$7,103,413
Petter Bjornstad · University Of Colorado Denver$6,549,851
Xinhua Li · Nano Terra, Inc.$6,087,655
Laura Perin · Children'S Hospital Of Los Angeles$4,571,214
Jennifer A. Lewis · Harvard University$4,481,731
Meghan E. Sise · Massachusetts General Hospital$3,916,780

Research focus

Glomerular FiltrationMediatingEndothelial CellsGlomerular EndotheliumIn VitroLos AngelesDrug DevelopmentDrug ScreeningEvaluationGlomerular Basement MembraneHealthcareHormonesIn Vitro ModelKidneyAlbuminsDisease ProgressionCellsDrug DiscoveryChronic Kidney FailureEnsureExposure ToFiltration3-DimensionalMembranous Glomerulonephritis

Grant awards (2)

Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies$1,000,000

R44 · FY2022 · DK · contact PI

Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies$236,779

R43 · FY2020 · DK · contact PI